Edition:
United Kingdom

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

70.68SEK
19 Jan 2018
Change (% chg)

1.28kr (+1.84%)
Prev Close
69.40kr
Open
69.50kr
Day's High
70.98kr
Day's Low
69.38kr
Volume
1,791,179
Avg. Vol
1,365,472
52-wk High
95.90kr
52-wk Low
66.12kr

Latest Key Developments (Source: Significant Developments)

C-Rad Updates On Delivery To Swedish Cancer Center
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - C-Rad Ab ::REG-UPDATE ON C-RAD DELIVERY OF ITS ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA.SAYS ‍IS IN CLOSE DIALOGUE WITH CUSTOMER AND WITH ELEKTA TO DETERMINE STEPS FORWARD.​.  Full Article

Elekta reaches agreement in dispute with Stockholm County Council
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Elekta AB ::ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD.SAYS ELEKTA AND STOCKHOLM COUNTY COUNCIL SIGNED A LETTER OF INTENT TODAY REGARDING THE AGREEMENT FROM DECEMBER 29, 2016.SAYS ‍ELEKTA WILL CONTINUE TO FULLY EQUIP NEW RADIATION THERAPY DEPARTMENT OF STOCKHOLM SOUTH GENERAL HOSPITAL (SÖS) AND TO PROVIDE BRACHYTHERAPY SOLUTIONS TO NEW KAROLINSKA SOLNA (NKS).SAYS STOCKHOLM COUNTY COUNCIL WILL HAVE THE POSSIBILITY TO SEEK A SEPARATE SOLUTION FOR THE REMAINING EXTERNAL BEAM EQUIPMENT AT NKS​.SAYS VALUE OF REMAINING PART OF CONTRACT IS EXPECTED TO BE APPROXIMATELY SEK 160 MILLION; INITIAL ORDER VALUE WAS APPROXIMATELY SEK 350 MILLION.SAYS ‍LETTER OF INTENT IS EXPECTED TO BE TURNED INTO A BINDING CONTRACT LATEST JANUARY 31, 2018​.  Full Article

Elekta CEO: Unity radiation therapy system a 2018 sales driver
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Elekta AB CEO Richard Hausmann and CFo Gustaf Salford in a conference call with analysts and media::CEO SAYS OVERALL, THE UNITY RADIATION THERAPY PROJECT IS PROGRESSING VERY WELL.CFO SAY SEES FULL-YEAR POSITIVE CURRENCY EFFECT ON EBITA AT AROUND 150 MILLION SEK Y/Y.CEO SAYS EXPECTS UNITY RADIATION THERAPY SYSTEM TO BE A SALES GROWTH DRIVER IN 2018.  Full Article

Elekta Q2 core profit beat expectations, orders lag
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Elekta Ab ::Q2 ‍GROSS ORDER INTAKE AMOUNTED TO SEK 3,267 M (3,383),​.SAYS ‍OUR TARGETS FOR YEAR ARE CLEAR - WE WILL DELIVER PROFITABLE GROWTH AND REACH AN EBITA MARGIN EXCEEDING 20 PERCENT THROUGH GROWTH AND OUR WORK WITH CONTINUOUS OPERATIONAL IMPROVEMENTS​.Q2 ‍NET SALES WAS SEK 2,802 M (2,434)​.Q2 ‍ADJUSTED EBITA* AMOUNTED TO SEK 509 M (391)​.REUTERS POLL: ELEKTA FISCAL Q2 ORDER INTAKE SEEN AT SEK 3.5 BILLION, ADJUSTED EBITA AT SEK 432 MILLION.REUTERS POLL: ELEKTA FISCAL Q2 ORDER INTAKE SEEN AT SEK 3.5 BILLION, ADJUSTED EBITA AT SEK 432 MILLION.SAYS ON ELEKTA UNITY: WE ADJUST OUR TARGET FOR THE FIRST 75 ORDERS TO THE FIRST HALF OF CALENDAR YEAR 2020‍​.  Full Article

Elekta says CE mark for Unity is expected during first half of 2018
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Elekta Ab (Publ) :Elekta has decided to add additional functional imaging capabilities to its MR-linac (Unity) and to spend more time on validating its linac control system .CE mark for Unity is currently expected during the first half of 2018 instead of the end of 2017..  Full Article

Elekta says on track to reach targets of transformation program
Monday, 26 Sep 2016 

Elekta AB : Says company is on track to reach targets of its transformation program .Says these targets include an EBITA margin of 20 percent in 2017/18; cost reductions of SEK 700 million, with full effect 2017/18; and a net working capital to sales ratio below five percent in 2016/17.  Full Article

Elekta Q1 core profit tops forecast
Thursday, 1 Sep 2016 

Elekta AB : Q1 EBITA, adjusted for items affecting comparability and bad debt losses, amounted to SEK 166 m (68) . Reuters poll: Elekta adjusted EBITA at SEK 80 million . Elekta Q1 gross order intake increased by 4 percent to SEK 2,662 m (2,569) . Q1 items affecting comparability was SEK -89 m (-30) and bad debt losses was SEK -6 m (-27) . Net sales decreased 16 percent to SEK 1,882 M (2,239) and 15 percent based on constant exchange rates . Says our target is to reduce cost base with SEK 700 m compared with 2014/15 and we are half way through process .Says order growth in china was particularly strong with an increase of 30 percent.  Full Article

Elekta core earnings undershoot, says first half of fiscal 2016/17 to be weak
Wednesday, 1 Jun 2016 

Elekta AB : Says board of directors proposes a dividend of sek 0.50 (0.50) per share for fiscal year 2015/16 and that dividend will be divided into two payments from now on . Q4 EBITA, adjusted for non-recurring items and bad debt losses, amounted to SEK 785 m (739). Non-Recurring items was SEK -459 m (-1) and bad debt losses was SEK -43 m (-138) . Q4 net order bookings increased 17 percent to sek 4,520 m (3,856) and increased 16 percent based on constant exchange rate . Reuters poll: Elekta Q4 order bookings were seen at SEK 4,303 million, adjusted EBITA at SEK 905 million, dividend per share SEK 0.72 . Says to further reduce inventories, will undertake temporary reduced production and shipment volume, with a one-off negative revenue impact estimated at about sek 500 m in first half of fiscal year 2016/17 . Says expects a weak result during first half of fiscal year 2016/17 . Says additional expected costs related to transformation are estimated to be approximately SEK 300 m and will be charged as a non-recurring item during fiscal 2016/17 . Says going forward Elekta will not provide a net sales outlook . Says targets for transformation program include reaching an EBIT margin of 20 percent in fiscal year 2017/18 .Says also includes to realize cost reductions of SEK 700 m with full effect from 2017/18.  Full Article

Elekta says Leksell Gamma Knife Icon cleared for use in Japan, US
Wednesday, 1 Jun 2016 

Elekta Publ AB :Elekta's Leksell Gamma Knife Icon cleared for use in Japan and United States.  Full Article

Elekta to pay 8.9 million euro in legal dispute
Tuesday, 24 May 2016 

Elekta Publ Ab : Elekta to pay humediQ eur 8.9 million in legal dispute . An arbitration tribunal in London issued an award in a dispute between two Elekta group companies and humediQ GmbH . The tribunal determined that the Elekta companies did not validly terminate a 2011 agreement and that, as a result, they must pay humediQ approximately 8.9 million euro . In addition, Elekta will write off approximately 5 million euro connected to payments made under the agreement. .Says the negative result of approximately 14 million euro will be taken in the fourth quarter of Elekta's fiscal year 2015/16 as a non-recurring item.  Full Article

BRIEF-C-Rad Updates On Delivery To Swedish Cancer Center

* REG-UPDATE ON C-RAD DELIVERY OF ITS ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA